1-5 of 5
Gitte Olesen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of t(9;11) and Del(7q) As Intermediate-Risk Abnormalities in AML Following Allo-Transplant: Insights from the ELN 2022 Classification - an EBMT ALWP Study

Iman Abou Dalle, Jaques-Emmanuel Galimard, Ali Bazarbachi, Gerard Socie, Patrice Chevallier, Peter Dreger, Gitte Olesen, Ibrahim Yakoub-Agha, Jurjen Versluis, Jurgen Kuball, Igor Wolfgang Blau, Hélène Labussière-Wallet, Thomas Heinicke, Dominik Schneidawind, Tobias A.W. Holderried, Keith Wilson, Thomas Schroeder, Frederic Baron, Eolia Brissot, Jordi Esteve, Arnon Nagler, Mohamad Mohty, Fabio Ciceri
Journal: Blood
Blood (2024) 144 (Supplement 1): 4945.
https://doi.org/10.1182/blood-2024-204824
Published: 2024
Journal Articles

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Lin Li, Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Depei Wu, Jia Chen, Nicolaus Kröger, Jakob Passweg, Sr., Urpu Salmenniemi, Maija Itäla-remes, Xavier Poiré, Matthias Eder, Johan Maertens, David Burns, Henrik Sengeloev, Gitte Olesen, Didier Blaise, Jürgen Finke, Alain Gadisseur, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Yi Luo, Jimin Shi, Fabio Ciceri, Mohamad Mohty, He Huang, Norbert Claude Gorin, Sr.
Journal: Blood
Blood (2023) 142 (Supplement 1): 4986.
https://doi.org/10.1182/blood-2023-185685
Published: 2023
Journal Articles

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation

Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles Craddock, Eva Maria Wagner, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus Kröger, Victoria Potter, Edouard Forcade, Jakob Passweg, Régis Peffault de Latour, Johan Maertens, Keith Wilson, Jean-Henri Bourhis, Bipin Savani, Fabio Ciceri, Arnon Nagler, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 2389–2391.
https://doi.org/10.1182/blood-2022-157890
Published: 2022
Journal Articles

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Magnus Tobiasson, MD, Tatjana Pandzic, PhD, Johanna Illman, Lars Nilsson, PhD, Simone Weström, Daniel Olsson, Elisabeth Ejerblad, MD, Astrid Olsnes Kittang, Gitte Olesen, Olle Werlenius, Andreas T Björklund, MD PhD MSc, Fryderyk Lorentz, Bengt Erik Holger Rasmussen, Jörg Cammenga, MD, Duruta Weber, Marios Dimitriou, PhD, Soili Kytölä, PhD, Gunilla Walldin, Kirsten Groenbaek, MD DMSc, Stephan Mielke, MD, Sten Eirik Waelgaard Jacobsen, MD PhD, Freja Ebeling, MD PhD, Lucia Cavelier, PhD, Lone Smidstrup Friis, MD PhD, Ingunn Dybedal, MD PhD, Eva Hellstrom Lindberg, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-138782
Published: 2020
Journal Articles

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Brenda M Sandmaier, MD, David G Maloney, MD PhD, Barry E. Storer, PhD, Gitte Olesen, MD, Michael B. Maris, MD, Jonathan A Gutman, MD, Soren Lykke Petersen, MD DMSC, Amelia Langston, MD, Thomas Chauncey, Wolfgang Bethge, MD, Michael A Pulsipher, MD, Brian Thomas Kornblit, MD PhD, Ann E Woolfrey, MD, Marco Mielcarek, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD, Rainer F. Storb, MD
Journal: Blood
Blood (2016) 128 (22): 506.
https://doi.org/10.1182/blood.V128.22.506.506
Published: 2016